SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
The Neuroscientist
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (27)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Beeton, C.
Right arrow Articles by Chandy, K. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beeton, C.
Right arrow Articles by Chandy, K. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Potassium Channels, Memory T Cells, and Multiple Sclerosis

Christine Beeton

Department of Physiology and Biophysics, Medical School, University of California, Irvine

K. George Chandy

Department of Physiology and Biophysics, Medical School, 346-D Med. Sci. I, University of California, Irvine, Irvine, CA 92697 gchandy{at}uci.edu

Multiple sclerosis is a chronic inflammatory autoimmune disease of the central nervous system characterized by demyelination and axonal damage that result in disabling neurological deficits. Here the authors explain the rationale for the use of inhibitors of the Kv1.3 K+ channel in immune cells as a therapy for multiple sclerosis and other autoimmune disorders.

Key Words: Potassium channels • Memory lymphocytes • Autoimmunity • Multiple sclerosis • Kv1.3

The Neuroscientist, Vol. 11, No. 6, 550-562 (2005)
DOI: 10.1177/1073858405278016


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J. Cell Sci.Home page
L. Sole, M. Roura-Ferrer, M. Perez-Verdaguer, A. Oliveras, M. Calvo, J. M. Fernandez-Fernandez, and A. Felipe
KCNE4 suppresses Kv1.3 currents by modulating trafficking, surface expression and channel gating
J. Cell Sci., October 15, 2009; 122(20): 3738 - 3748.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
K. AKAMATSU, M.-A. SHIBATA, Y. ITO, Y. SOHMA, H. AZUMA, and Y. OTSUKI
Riluzole Induces Apoptotic Cell Death in Human Prostate Cancer Cells via Endoplasmic Reticulum Stress
Anticancer Res, June 1, 2009; 29(6): 2195 - 2204.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Han, H. Yi, S.-J. Yin, Z.-Y. Chen, H. Liu, Z.-J. Cao, Y.-L. Wu, and W.-X. Li
Structural Basis of a Potent Peptide Inhibitor Designed for Kv1.3 Channel, a Therapeutic Target of Autoimmune Disease
J. Biol. Chem., July 4, 2008; 283(27): 19058 - 19065.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. G. Meuth, S. Bittner, P. Meuth, O. J. Simon, T. Budde, and H. Wiendl
TWIK-related Acid-sensitive K+ Channel 1 (TASK1) and TASK3 Critically Influence T Lymphocyte Effector Functions
J. Biol. Chem., May 23, 2008; 283(21): 14559 - 14570.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Vicente, N. Villalonga, M. Calvo, A. Escalada, C. Solsona, C. Soler, M. M. Tamkun, and A. Felipe
Kv1.5 Association Modifies Kv1.3 Traffic and Membrane Localization
J. Biol. Chem., March 28, 2008; 283(13): 8756 - 8764.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
L. E. Pereira, F. Villinger, H. Wulff, A. Sankaranarayanan, G. Raman, and A. A. Ansari
Pharmacokinetics, Toxicity, and Functional Studies of the Selective Kv1.3 Channel Blocker 5-(4-Phenoxybutoxy)Psoralen in Rhesus Macaques
Experimental Biology and Medicine, November 1, 2007; 232(10): 1338 - 1354.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. H. Nam, H.-S. Lee, Y. H. Nguyen, T. M. Kang, S. W. Lee, H.-Y. Kim, S. J. Kim, Y. E. Earm, and S. J. Kim
Mechanosensitive activation of K+ channel via phospholipase C-induced depletion of phosphatidylinositol 4,5-bisphosphate in B lymphocytes
J. Physiol., August 1, 2007; 582(3): 977 - 990.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Vicente, A. Escalada, N. Villalonga, L. Texido, M. Roura-Ferrer, M. Martin-Satue, C. Lopez-Iglesias, C. Soler, C. Solsona, M. M. Tamkun, et al.
Association of Kv1.5 and Kv1.3 Contributes to the Major Voltage-dependent K+ Channel in Macrophages
J. Biol. Chem., December 8, 2006; 281(49): 37675 - 37685.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Beeton, H. Wulff, N. E. Standifer, P. Azam, K. M. Mullen, M. W. Pennington, A. Kolski-Andreaco, E. Wei, A. Grino, D. R. Counts, et al.
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
PNAS, November 14, 2006; 103(46): 17414 - 17419.
[Abstract] [Full Text] [PDF]



Advertisement